The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis

International Journal of Oncology

Volumn 45, Issue 1, 2014, Pages 197-208

  Li, Hailong ^a,b   Xie, Shoupin ^c   Liu, Min ^a   Chen, Zhaofeng ^a,b   Liu, Xiaojun ^a   Wang, Li ^a   Li, Dayan ^a   Zhou, Yongning ^a,b  

^a LANZHOU UNIVERSITY   (China)

^b Orthopaedics Key Laboratory of Gansu Province   (China)

^c Lanzhou First People's Hospital   (China)

Author keywords

Gastric cancer; miRNA; PCR array; Tumor suppressors

Indexed keywords

MICRORNA; MICRORNA 124; MICRORNA 146A; MICRORNA 155; MICRORNA 355; UNCLASSIFIED DRUG; MIRN124 MICRORNA, HUMAN; MIRN146 MICRORNA, HUMAN; MIRN155 MICRORNA, HUMAN; MIRN335 MICRORNA, HUMAN;

ADULT; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL INVASION; DOWN REGULATION; FEMALE; GASTRIC CANCER CELL LINE; GENE EXPRESSION; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STOMACH CANCER; TUMOR INVASION; AGED; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STOMACH NEOPLASMS;

EID: 84902587983     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2415     Document Type: Article

References (38)

1. Bartels CL and Tsongalis GJ: MicroRNAs: novel biomarkers for human cancer. Clin Chem 55: 623-631, 2009.
2. Cortes-Sempere M and Ibanez de Caceres I: microRNAs as novel epigenetic biomarkers for human cancer. Clin Transl Oncol 13: 357-362, 2011.
3. Shenouda SK and Alahari SK: MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev 28: 369-378, 2009.
4. Callari M, Dugo M, Musella V, et al: Comparison of microarray platforms for measuring differential microRNA expression in paired normal/cancer colon tissues. PLoS One 7: e45105, 2012.
5. D'Andrade PN and Fulmer-Smentek S: Agilent microRNA microarray profiling system. Methods Mol Biol 822: 85-102, 2012.
6. Jang JS, Simon VA, Feddersen RM, et al: Quantitative miRNA expression analysis using fluidigm microfluidics dynamic arrays. BMC Genomics 12: 144, 2011.
7. Ranade AR and Weiss GJ: Methods for microRNA microarray profiling. Methods Mol Biol 700: 145-152, 2011.
8. Srivastava S, Srivastava AK, Suprasanna P and D'Souza SF: Identification and profiling of arsenic stress-induced microRNAs in Brassica juncea. J Exp Bot 64: 303-315, 2013.
9. Katada T, Ishiguro H, Kuwabara Y, et al: microRNA expression profile in undifferentiated gastric cancer. Int J Oncol 34: 537-542, 2009.
10. Li X, Zhang Y, Zhang H, et al: miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res 9: 824-833, 2011.
11. Gao M, Yin H and Fei ZW: Clinical application of microRNA in gastric cancer in Eastern Asian area. World J Gastroenterol 19: 2019-2027, 2013.
12. Carvalho J, van Grieken NC, Pereira PM, et al: Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J Pathol 228: 31-44, 2012.
13. Guo J, Miao Y, Xiao B, et al: Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol 24: 652-657, 2009.
14. Li X, Luo F, Li Q, et al: Identification of new aberrantly expressed miRNAs in intestinal-type gastric cancer and its clinical significance. Oncol Rep 26: 1431-1439, 2011.
15. Luo H, Zhang H, Zhang Z, et al: Down-regulated miR-9 and miR-433 in human gastric carcinoma. J Exp Clin Cancer Res 28: 82, 2009.
16. Tsukamoto Y, Nakada C, Noguchi T, et al: MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta. Cancer Res 70: 2339-2349, 2010.
17. Ueda T, Volinia S, Okumura H, et al: Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146, 2010.
18. Yao Y, Suo AL, Li ZF, et al: MicroRNA profiling of human gastric cancer. Mol Med Rep 2: 963-970, 2009.
19. Zhang Z-Y, Wu Z-Q and Wang H-J: An analysis of gastric cancer detection and epidemicity in high incidental area with gastric cancer, Wuwei City, Gansu Province. China Cancer 10: 014, 2009.
20. Li Y-M, Shi B, Li X, Zhou W-N, Liu H and Mi D-H: Study of the characteristics of gastric carcinoma in Wuwei City of Gansu province. Zhonghua pu tong wai ke za zhi 13: 667-669, 2004 (In Chinese).
21. Kim CH, Kim HK, Rettig RL, et al: miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med Genomics 4: 79, 2011.
22. Kong D, Piao YS, Yamashita S, et al: Inflammation-induced repression of tumor suppressor miR-7 in gastric tumor cells. Oncogene 31: 3949-3960, 2012.
23. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y: Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology 77: 12-21, 2009.
24. Wen D, Li S, Ji F, et al: miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol 34: 793-803, 2013.
25. Zhao X, Dou W, He L, et al: MicroRNA-7 functions as an antimetastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 32: 1363-1372, 2013.
26. Zhao Y, Huang J, Zhang L, et al: MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer 14: 34, 2014.
27. Xia J, Wu Z, Yu C, et al: miR-124 inhibits cell proliferation in gastric cancer through down-regulation of SPHK1. J Pathol 227: 470-480, 2012.
28. Kogo R, Mimori K, Tanaka F, Komune S and Mori M: Clinical significance of miR-146a in gastric cancer cases. Clin Cancer Res 17: 4277-4284, 2011.
29. Yao Q, Cao Z, Tu C, Zhao Y, Liu H and Zhang S: MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 335: 219-224, 2013.
30. Hou Z, Xie L, Yu L, Qian X and Liu B: MicroRNA-146a is downregulated in gastric cancer and regulates cell proliferation and apoptosis. Med Oncol 29: 886-892, 2012.
31. Hou Z, Yin H, Chen C, et al: microRNA-146a targets the L1 cell adhesion molecule and suppresses the metastatic potential of gastric cancer. Mol Med Rep 6: 501-506, 2012.
32. Crone SG, Jacobsen A, Federspiel B, et al: microRNA-146a inhibits G protein-coupled receptor-mediated activation of NF-kappaB by targeting CARD10 and COPS8 in gastric cancer. Mol Cancer 11: 71, 2012.
33. Xiao B, Zhu ED, Li N, et al: Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol Rep 27: 559-566, 2012.
34. Kim BH, Hong SW, Kim A, Choi SH and Yoon SO: Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma. J Surg Oncol 107: 505-510, 2013.
35. Liu L, Chen Q, Lai R, et al: Elevated expression of mature miR-21 and miR-155 in cancerous gastric tissues from Chinese patients with gastric cancer. J Biomed Res 24: 187-197, 2010.
36. Li CL, Nie H, Wang M, et al: microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis. Oncol Rep 27: 1960-1966, 2012.
37. Xu Y, Zhao F, Wang Z, et al: MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Oncogene 31: 1398-1407, 2012.
38. Yan Z, Xiong Y, Xu W, et al: Identification of hsa-miR-335 as a prognostic signature in gastric cancer. PLoS One 7: e40037, 2012.